Engineering Microbes for Mucosal Drug Delivery

Tenza reprograms symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit. We do so using a ML-powered, synthetic biology platform that enables us to engineer a wider diversity of bacteria to produce higher yields of drugs than ever before.

Tenza Team


Scientific Advisory Board

Rob Britton, Ph.D.

Wendy Garrett, M.D., Ph.D.

Steve Landau, M.D.

John March, Ph.D.

Hank Talbot, Ph.D.

Todd Zion, Ph.D.


700 Main St., Cambridge, MA, USA

George Church, Ph.D.


Anik Debnath, Ph.D.

Co-founder & CEO

Todd Krueger

Executive Director

Denise Sirias, Ph.D.

Principal Scientist

Ameet Shetty, Ph.D.

Principal Scientist 

Devon Stork, Ph.D.

Principal Scientist